Correlation Between Victory Integrity and MIRA Pharmaceuticals,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Victory Integrity and MIRA Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Victory Integrity and MIRA Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Victory Integrity Smallmid Cap and MIRA Pharmaceuticals, Common, you can compare the effects of market volatilities on Victory Integrity and MIRA Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Victory Integrity with a short position of MIRA Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Victory Integrity and MIRA Pharmaceuticals,.

Diversification Opportunities for Victory Integrity and MIRA Pharmaceuticals,

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between Victory and MIRA is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Victory Integrity Smallmid Cap and MIRA Pharmaceuticals, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MIRA Pharmaceuticals, and Victory Integrity is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Victory Integrity Smallmid Cap are associated (or correlated) with MIRA Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MIRA Pharmaceuticals, has no effect on the direction of Victory Integrity i.e., Victory Integrity and MIRA Pharmaceuticals, go up and down completely randomly.

Pair Corralation between Victory Integrity and MIRA Pharmaceuticals,

Assuming the 90 days horizon Victory Integrity Smallmid Cap is expected to under-perform the MIRA Pharmaceuticals,. But the mutual fund apears to be less risky and, when comparing its historical volatility, Victory Integrity Smallmid Cap is 5.44 times less risky than MIRA Pharmaceuticals,. The mutual fund trades about -0.07 of its potential returns per unit of risk. The MIRA Pharmaceuticals, Common is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  114.00  in MIRA Pharmaceuticals, Common on December 28, 2024 and sell it today you would earn a total of  1.00  from holding MIRA Pharmaceuticals, Common or generate 0.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy98.36%
ValuesDaily Returns

Victory Integrity Smallmid Cap  vs.  MIRA Pharmaceuticals, Common

 Performance 
       Timeline  
Victory Integrity 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Victory Integrity Smallmid Cap has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Victory Integrity is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
MIRA Pharmaceuticals, 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in MIRA Pharmaceuticals, Common are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile basic indicators, MIRA Pharmaceuticals, may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Victory Integrity and MIRA Pharmaceuticals, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Victory Integrity and MIRA Pharmaceuticals,

The main advantage of trading using opposite Victory Integrity and MIRA Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Victory Integrity position performs unexpectedly, MIRA Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MIRA Pharmaceuticals, will offset losses from the drop in MIRA Pharmaceuticals,'s long position.
The idea behind Victory Integrity Smallmid Cap and MIRA Pharmaceuticals, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets